Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

View:
Post by Golddetector on Sep 11, 2022 9:23am

Reduvo

We should be in revenue since Q1 and yet we are in September now and we still waiting. I hope we finally get it this month it is going to be almost 1 year behind schedule. Although the hault this week provided a very good news by finally taking qrd003 off the ground with this partnership but let's hope the next hault is Reduvo. This will easily bring us back to 20s cents or maybe 30s.
Comment by JACKTHEBEAR2 on Sep 12, 2022 11:35am
According to Tetra it is still in final stage review so the wait continues. Perhaps a halt in a very positive way is in our near future.
Comment by SamV21 on Sep 12, 2022 12:41pm
https://ir.tetrabiopharma.com/newsroom/press-releases/news-details/2020/Tetra-Bio-Pharma-Files-New-Drug-Submission-for-REDUVOTM-in-Canada/default.aspx According to Tetra and Guy we would be marketing Reduvo in 2021 and have 80 million in revenue from Reduvo in 2022 , I guess that was to keep us all by our phones as 2020 was going to be the break out year , NO ONE BELIEVES A WORD THAT GUY SAYS ANY ...more  
Comment by Humanist on Sep 20, 2022 8:51am
 I've been in tbp for a long time, butI really lost faith after so many failed promises and nothing coming to fruition except that they tell us there are many products in the pipeline etc..  but 3 yrs ago they were waiting for fda response/approval on i don't remeber which one, than nothing... than they had to retest some products bcthe cannabis they were using was sontaminated. ...more  
Comment by JohnnyRingo20 on Sep 20, 2022 9:21am
someone with actual logic and can see things for what they are. Smoke and mirrors   you're few and far between.   
Comment by Normandt on Sep 20, 2022 2:33pm
Reduvo is already approved by the fda. On the Health Canada web site the same 10 drugs/products under review....at the top of the list are the same for around 6 months now....then there is no relation with TBP at all. //////////// Erwinia L-asparaginase Antineoplastic agents 2021-09 Porton Biopharma Limited Being reviewed under the Priority Review Policy Acetaminophen Analgesics 2021-04 B. Braun ...more  
Comment by SamV21 on Sep 20, 2022 2:44pm
Reduvo is not sold or approved any where in the world .Its a different product , different company , once again if that is true Guy is just copying old science and it is worth nothing .
Comment by Golddetector on Sep 20, 2022 4:55pm
Not sure why it is taking so long. The sp was under pressure past few days. I was waiting but today I decided to start averaging down. There are no grounds for health Canada to reject or delay this further since it is already in use in us uk Australia South Africa. Matter of time.
Comment by JohnnyRingo20 on Sep 21, 2022 9:01am
No reason not to pass it?  If it's approved everywhere else, why are we even going through trials?  Why are we trying to bring it to market? Does Guy think we can compete with other companies already approved etc? no logic..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities